Ketamine Trial Aims to Blunt Depression, Craving and Relapse in Opioid Use Disorder
A phase II randomised, double-blind, placebo-controlled trial in Cyprus will test whether six intravenous ketamine infusions can reduce depressive symptoms, ...
Tag: MOUD
Legal Uncertainty, Not Lack of Knowledge, Keeps Doctors From Treating Teens With Opioid Use Disorder
A survey of 600 US pediatric prescribers finds that legal uncertainty, practice setting, and beliefs about medication, rather than clinician ...
Peer-Led Videos Could Persuade Primary Care Doctors to Treat Opioid Addiction
Targeted educational videos featuring a rural physician's experience with buprenorphine significantly reduced perceived barriers and increased primary care practitioners' intention ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!